NIH #N01CN005126
PHASE II CLINICAL TRIAL OF CELECOXIB IN PERSONS WITH GE
- Amount
- $3M–$4M
- Period
- 2000-09-30 → 2005-09-29
- PIs
- 1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Patrick M. Lynch
Full Professor(heuristic)
Genetic factors in colorectal cancer · Pathology and Forensic Medicine
Compare more Pathology and Forensic Medicine professors.
h-index70
i10-index195
Publications541
Citations22,044
Grants
4 total · 0 active
NIH #N01CN075021
PHASE II MULTIPLE-DOSE SAFETY & EFFICACY STUDY OF A SELE
- Amount
- $1M–$2M
- Period
- 1997-04-30 → 1999-07-31
- PIs
- 1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #R03CA051646
CALCIUM MODULATION OF COLON CANCER INTERMEDIATE MARKERS
- Amount
- <$100K
- Period
- 1989-09-10 → 1990-08-31
- PIs
- 1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures (Nature Communications)2026-04-03
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-04
Data may not be current
Find elsewhere
ORCID: 0000-0003-0125-3109